453 related articles for article (PubMed ID: 26752510)
1. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge.
Clapp B; Yang X; Thornburg T; Walters N; Pascual DW
Immunol Cell Biol; 2016 May; 94(5):496-508. PubMed ID: 26752510
[TBL] [Abstract][Full Text] [Related]
2. Live mucosal vaccination stimulates potent protection
Goodwin ZI; Yang X; Hoffman C; Pascual DW
Front Immunol; 2022; 13():995327. PubMed ID: 36263034
[TBL] [Abstract][Full Text] [Related]
3. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
[TBL] [Abstract][Full Text] [Related]
4. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
Wang H; Hoffman C; Yang X; Clapp B; Pascual DW
PLoS Pathog; 2020 Jan; 16(1):e1008176. PubMed ID: 31951645
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.
Durward-Diioia M; Harms J; Khan M; Hall C; Smith JA; Splitter GA
Infect Immun; 2015 Dec; 83(12):4759-71. PubMed ID: 26416901
[TBL] [Abstract][Full Text] [Related]
6. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
Yang X; Clapp B; Thornburg T; Hoffman C; Pascual DW
Vaccine; 2016 Oct; 34(44):5290-5297. PubMed ID: 27639282
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
9. Identification of Immune Effectors Essential to the Control of Primary and Secondary Intranasal Infection with Brucella melitensis in Mice.
Hanot Mambres D; Machelart A; Potemberg G; De Trez C; Ryffel B; Letesson JJ; Muraille E
J Immunol; 2016 May; 196(9):3780-93. PubMed ID: 27036913
[TBL] [Abstract][Full Text] [Related]
10. A Single Nasal Dose Vaccination with a Brucella abortus Mutant Potently Protects against Pulmonary Infection.
Wang H; Clapp B; Hoffman C; Yang X; Pascual DW
J Immunol; 2023 May; 210(10):1576-1588. PubMed ID: 37036290
[TBL] [Abstract][Full Text] [Related]
11. Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.
Vitry MA; De Trez C; Goriely S; Dumoutier L; Akira S; Ryffel B; Carlier Y; Letesson JJ; Muraille E
Infect Immun; 2012 Dec; 80(12):4271-80. PubMed ID: 23006848
[TBL] [Abstract][Full Text] [Related]
12. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
[TBL] [Abstract][Full Text] [Related]
13. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.
Muñoz-Montesino C; Andrews E; Rivers R; González-Smith A; Moraga-Cid G; Folch H; Céspedes S; Oñate AA
Infect Immun; 2004 Apr; 72(4):2081-7. PubMed ID: 15039330
[TBL] [Abstract][Full Text] [Related]
14. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
[TBL] [Abstract][Full Text] [Related]
15. The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by
Muñoz González F; Sycz G; Alonso Paiva IM; Linke D; Zorreguieta A; Baldi PC; Ferrero MC
Front Immunol; 2019; 10():1775. PubMed ID: 31402921
[No Abstract] [Full Text] [Related]
16. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
17. Mucosal Vaccination Primes NK Cell-Dependent Development of CD8
Bhagyaraj E; Wang H; Yang X; Hoffman C; Akgul A; Goodwin ZI; Pascual DW
Front Immunol; 2021; 12():697953. PubMed ID: 34305935
[TBL] [Abstract][Full Text] [Related]
18. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
